EnGeneIC Ltd. (ABN: 59 091 336 499) — Form D
EnGeneIC Ltd. (ABN: 59 091 336 499) of LANE COVE, NEW SOUTH WALES, C3, a company, filed a Form D exempt-offering notice with the SEC on 2015-03-02. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-03-02
- Form: D
- Accession: 0000897069-15-000175
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $7.0M
- Investors: 4
- Date of first sale: 2014-08-25
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-234973
Issuer
- Name: EnGeneIC Ltd. (ABN: 59 091 336 499)
- CIK: 0001522586
- Entity type: Other
- Jurisdiction: AUSTRALIA
- Address: BUILDING 2, LANE COVE, NEW SOUTH WALES, C3, 2066
- Phone: 61 2 9420 5844
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Himanshu Brahmbhatt | Director | New South Wales, C3 |
| William Louis Delaat | Director | New South Wales, C3 |
| Jennifer MacDiarmid | Director | New South Wales, C3 |
| Mervyn John Turner | Director | New South Wales, C3 |
| Stuart Wardman-Browne | Director | Sidney, C3 |
| Richard Woods | Director | Lebanon, NH |
| Himanshu Brahmbhatt | Executive Officer | New South Wales, C3 |
| Anjan Chatterji | Executive Officer | New York, NY |
| Jennifer MacDiarmid | Executive Officer | New South Wales, C3 |
| David Seaton | Executive Officer | New South Wales, C3 |
| Roger Moore | Director | Fort Lauderdale, FL |
| Robert Graham | Director | Atlanta, GA |
| Graham Cole | Executive Officer | Lane Cove, New South Wales, C3 |
| Ergad Gold | Director | Melbourne Victoria, C3 |
Other filings by this issuer (3)
More